Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial

Pasi A. Jänne, Xiaofei Wang, Mark A. Socinski, Jeffrey Crawford, Thomas E. Stinchcombe, Lin Gu, Marzia Capelletti, Martin J. Edelman, Miguel A. Villalona-Calero, Robert Kratzke, Everett E. Vokes, Vincent A. Miller

Research output: Contribution to journal › Article › peer-review

196 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences